Fund moves
16 tracked managers disclosed the same change for Q2 2026. From a 13F filed Jul 30, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 29, 2026 · Filed Jul 1, 2026
A Charles River Laboratories director sold $16.9M of Charles River Laboratories shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$16,875,000
Shares × reported transaction price
53 days after results of May 7, 2026, 37 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $225.57 on Jun 29, 2026, within 1% of its 52-week high, after a 42% rise over the previous 30 trading days
52-week range $145.57 (Sep 25, 2025) to $226.77 (Jan 21, 2026), 99% of the way up, from 251 adjusted closes. 30 trading days earlier: $159.12 on May 14, 2026. Describes the past only, not a forecast
RSI 77, 26% above its 200-day average, 27% above its 50-day average, 1% below the 52-week high, 20-day volatility 47% a year, against the S&P 500: +26 points over 1 month, +25 points over 3 months, +4 points over 6 months
From the adjusted closes up to Jun 29, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
James C Foster's largest sale of CRL in their filings since 2006
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.3% | +0.9% | +0.3% |
| 30 days | +0.1% | +1.7% | −1.6% |
| 90 days | +27.9% | +2.4% | +25.5% |
Past results only. Not a forecast.
Fund moves
16 tracked managers disclosed the same change for Q2 2026. From a 13F filed Jul 30, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
21 tracked managers disclosed the same change for Q2 2026. From a 13F filed Jul 24, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
16 tracked managers disclosed the same change for Q2 2026. From a 13F filed Jul 1, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.